Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Bladder cancer

Active surveillance for low-grade Ta bladder tumours

Active surveillance is a safe and cost-effective method to manage patients with recurrent papillary, low-grade, Ta bladder tumours. New long-term data from a large patient cohort confirm previous findings that emphasize the benefits of limiting the number of surgical procedures requiring anaesthesia and hospitalization in these, often elderly, patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hernández, V. et al. Long-term oncological outcomes of an active surveillance program in recurrent low grade Ta bladder cancer. Urol. Oncol. http://dx.doi.org/10.1016/j.urolonc.2015.11.005 (2015).

  2. Hernández, V. et al. Safety of active surveillance program for recurrent nonmuscle-invasive bladder carcinoma. Urology 73, 1306–1310 (2009).

    Article  Google Scholar 

  3. Vaidya, A., Soloway, M. S., Hawke, C., Tiguert, R. & Civantos, F. De novo muscle invasive bladder cancer: is there a change in trend? J. Urol. 165, 47–50 (2001).

    Article  CAS  Google Scholar 

  4. Prout, G. R. Jr, Barton, B. A., Griffin, P. P. & Friedell, G. H. Treated history of noninvasive grade 1 transitional cell carcinoma. J. Urol. 148, 1413–1419 (1992).

    Article  Google Scholar 

  5. Soloway, M. S. It is time to abandon the 'superficial' in bladder cancer. Eur. Urol. 52, 1564–1565 (2007).

    Article  Google Scholar 

  6. Soloway, M. S., Bruck, D. S. & Kim, S. S. Expectant management of small, recurrent, noninvasive papillary bladder tumors. J. Urol. 170, 438–441 (2003).

    Article  Google Scholar 

  7. Gofrit, O. N., Pode, D., Lazar, A., Katz, R. & Shapiro, A. Watchful waiting policy in recurrent Ta G1 bladder tumors. Eur. Urol. 49, 303–306 (2006).

    Article  Google Scholar 

  8. Pruthi, R. S., Baldwin, N., Bhalani, V. & Wallen, E. M. Conservative management of low risk superficial bladder tumors. J. Urol. 179, 87–90 (2008).

    Article  Google Scholar 

  9. Lokeshwar, S. D., Ruiz-Cordero, R., Hupe, M. C., Jorda, M. & Soloway, M. S. Impact of 2004 ISUP/WHO classification on bladder cancer grading. World J. Urol. 33, 1929–1936 (2015).

    Article  Google Scholar 

  10. Amin, M. B. et al. Update for the practicing pathologist: the International Consultation on Urologic Disease — European Association of Urology consultation on bladder cancer. Mod. Pathol. 28, 612–630 (2015).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark S. Soloway.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soloway, M. Active surveillance for low-grade Ta bladder tumours. Nat Rev Urol 13, 303–304 (2016). https://doi.org/10.1038/nrurol.2016.35

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2016.35

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing